Objectives The aim of this study was to evaluate the role of residue 238 in CTX-M-15 and CTX-M-15G238Cmutant with respect to carbapenems and various Î²-lactamase inhibitors. Methods A CTX-M-15G238Claboratory mutant was generated by site-directed mutagenesis from CTX-M-15 enzyme by replacing glycine 238 with cysteine. Thiol titration and p-chloromercuribenzoate (PCMB) inactivation assays were used to ascertain the presence of a disulfide bridge in the active site of CTX-M-15G238C. Kinetic parameters were determined both for CTX-M-15 and CTX-M-15G238Cenzymes by analysing either the complete hydrolysis time courses or under initial rate conditions. Results In CTX-M-15G238Cmutant, the two cysteines (C69 and C238) located in the enzyme active site were unable to form a disulfide bridge. CTX-M-15 and thermostable CTX-M-15G238Cwere used to study the kinetic interaction with carbapenems, which behaved as poor substrates for both enzymes. Meropenem and ertapenem acted as transient inactivators for CTX-M-15 and CTX-M-15G238C, and for these compounds the variation of kobsversus the inactivator concentration was linear. Imipenem behaved as a transient inactivator for CTX-M-15 and as an inactivator (with k+3Â =Â 0) for CTX-M-15G238C. In any case, the k+2/K values for CTX-M-15G238Cwere higher than those for CTX-M-15. Conclusions Compared with CTX-M-15, CTX-M-15G238Cmutant appears to have a more favourable conformation for carbapenem acylation and higher activity against cefotaxime, which could be due to the presence of free âSH groups in the enzyme active site.
|Titolo:||Interaction of carbapenems and Î²-lactamase inhibitors towards CTX-M-15 and CTX-M-15G238Cmutant|
|Data di pubblicazione:||2017|
|Appare nelle tipologie:||1.1 Articolo in rivista|